Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
28.55
-0.51 (-1.75%)
At close: Nov 5, 2026, 4:00 PM EST
29.56
+1.01 (3.54%)
After-hours: Nov 5, 2026, 7:30 PM EST

Viridian Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
172.86212.3899.59102.83155.5842.3
Short-Term Investments
782.35662.27617.99374.54268.97154.67
Cash & Short-Term Investments
955.21874.65717.58477.37424.55196.97
Cash Growth
94.58%21.89%50.32%12.44%115.55%54.31%
Receivables
29.78--0.10.10.45
Prepaid Expenses
26.7619.5820.889.016.522.65
Other Current Assets
-----0.1
Total Current Assets
1,013894.23738.46486.48431.17200.16
Property, Plant & Equipment
5.623.653.443.342.942.06
Other Long-Term Assets
0.131.540.50.60.981.49
Total Assets
1,029899.42742.4490.42435.09203.71

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.38.682.142.2414.232.33
Accrued Expenses
59.9560.8944.9323.1718.1110.4
Current Portion of Leases
0.810.750.510.840.610.52
Current Unearned Revenue
-0.370.290.290.290.29
Other Current Liabilities
---0.10.10.1
Total Current Liabilities
70.0570.747.8726.6433.3513.64
Long-Term Debt
242.4649.9420.5820.214.65-
Long-Term Leases
2.231.9-0.99--
Long-Term Unearned Revenue
---0.570.861.15
Other Long-Term Liabilities
133.2354.722.31-1.171.21
Total Liabilities
447.97177.2570.7648.440.0315.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1.141.020.810.540.410.24
Additional Paid-In Capital
2,1551,9271,478960.54741.07412.1
Retained Earnings
-1,672-1,338-995.86-725.91-488.17-358.3
Comprehensive Income & Other
-2.20.45-0.010.34-0.39-0.16
Total Common Equity
482.67590.11482.75235.51252.9253.88
Shareholders' Equity
580.7722.17671.64442.02395.06187.72
Total Liabilities & Equity
1,029899.42742.4490.42435.09203.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
245.552.5921.122.045.260.52
Net Cash (Debt)
709.71822.06696.49455.33419.29196.45
Net Cash Growth
52.07%18.03%52.96%8.60%113.44%54.46%
Net Cash Per Share
6.799.6910.2610.1713.0716.48
Filing Date Shares Outstanding
113.56102.2181.4862.7742.925.91
Total Common Shares Outstanding
113.53101.8380.9953.9941.3123.92
Working Capital
943.08823.54690.59459.84397.82186.53
Book Value Per Share
4.255.805.964.366.122.25
Tangible Book Value
472.88590.11482.75235.51252.9253.88
Tangible Book Value Per Share
4.175.805.964.366.122.25
Machinery
-2.172.252.052.221.4
Leasehold Improvements
-0.270.250.671.110.75
SEC Filings: 10-K · 10-Q